241 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
financial statements. ¨
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive … competitive salaries, stock ownership opportunities, and incentive and bonus programs. We also provide an expansive benefit offering including medical
8-K
bzpka51t napetq
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-1.1
z7lolhope5rzzb g9
13 Nov 23
Entry into a Material Definitive Agreement
4:31pm
424B5
5hly64aw1jj9to
13 Nov 23
Prospectus supplement for primary offering
6:02am
424B5
ppsq9dmpc7g2wyg4
8 Nov 23
Prospectus supplement for primary offering
4:05pm
144
4qfmewp4 ororsa5
1 Nov 23
Notice of proposed sale of securities
9:00pm
8-K
141y3u96b0y ooh
1 Nov 23
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.1
ibmo 366vzv8bz
5 Oct 23
Departure of Directors or Certain Officers
8:30am